Viral Testing Market Revenue was valued at USD 5.67 Billion in 2024 and is estimated to reach USD 9.82 Billion by 2033, growing at a CAGR of 7.1% from 2026 to 2033.
The European biomanufacturing sector is experiencing a significant surge in the demand for viral detection and quantification, driven by the increasing adoption of biopharmaceutical products. Ensuring the safety, efficacy, and consistency of these products necessitates stringent quality control measures, particularly in detecting viral contaminants during manufacturing processes. This emphasis on quality has led to a burgeoning market for viral testing applications across various industries.
In the realm of biomanufacturing, viral detection is paramount. Techniques such as Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), flow cytometry, and plaque assays are extensively utilized to identify and quantify viral contaminants. These methods are integral during various stages, including:
Raw Material Preparation: Ensuring that all inputs are free from viral agents to prevent contamination from the outset.
Upstream Processing: Monitoring cell cultures and fermentation processes to detect any viral presence early.
Downstream Processing: Verifying the purity of biopharmaceutical products during purification stages.
Packaging: Confirming that final products remain uncontaminated before reaching consumers.
The European market for biomanufacturing viral detection and quantification was valued at approximately $137.3 million in 2022 and is projected to reach $345.9 million by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 9.80% during the forecast period. This growth underscores the escalating importance of viral testing in maintaining the integrity of biopharmaceutical products.
Industries heavily reliant on viral testing include:
Blood and Blood Products Manufacturing: Ensuring the safety of blood transfusions by screening for viral pathogens.
Vaccines and Therapeutics Manufacturing: Guaranteeing that vaccines and therapeutic agents are free from viral contaminants, which is crucial for patient safety.
Cellular and Gene Therapy Products Manufacturing: Monitoring viral vectors used in gene therapy to prevent unintended consequences.
Stem Cell Products Manufacturing: Ensuring stem cell therapies are devoid of viral impurities to maintain treatment efficacy.
Tissue and Tissue Products Manufacturing: Verifying that transplanted tissues are safe and free from viral agents.
Recent regulatory developments have further shaped the landscape of viral testing in Europe. The implementation of the Regulation on In Vitro Diagnostic Medical Devices on May 26, 2022, introduced more stringent rules for placing medical tests on the EU market. This regulation emphasizes a risk-based classification system and mandates rigorous oversight by notified bodies, enhancing the reliability and performance of medical tests. Consequently, manufacturers must navigate these regulatory frameworks to ensure compliance and maintain market access.
Drawing parallels, the 100 Gigabit Fiber Optic Transceiver Market Application and requirement from industries have also seen substantial growth. The global market for these transceivers was valued at $474.3 million in 2022 and is anticipated to reach $1,149.7 million by 2032, reflecting a CAGR of 9.37% during the forecast period. This growth is propelled by the escalating demand for high-speed data transmission across various sectors, including data centers, telecommunications, and high-performance computing. The expansion of data centers, proliferation of cloud computing, and the rise of high-definition video streaming services necessitate robust and efficient networking solutions, thereby driving the demand for 100 Gigabit fiber optic transceivers.
In summary, the European viral testing market is poised for significant expansion, driven by the critical need to ensure the safety and efficacy of biopharmaceutical products. Industries must adopt advanced viral detection and quantification methods to comply with stringent regulatory standards and meet the increasing demand for safe medical products. Concurrently, the growth trajectory of the 100 Gigabit fiber optic transceiver market highlights the broader trend of technological advancements meeting industry requirements, underscoring the importance of innovation in addressing emerging challenges.
Get an In-Depth Research Analysis of the Europe Viral Testing Market Size And Forecast [2025-2032]
Roche
Agilent Technologies
Thermo Fisher Scientific
QIAGEN International
Lonza
Wuxi Pharmatech (Cayman)
Merck
Eurofins Scientific
General Electric
Danaher
Roche
BD
Biospherix
Novogene Corporation
Sartorius
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Europe region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Viral Testing Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Viral Testing Market
Bacterial Viruses
Animal Viruses
Plant Viruses
Human Viruses
Others
Cultivation Techniques
Molecular Techniques
Serological Techniques
Rapid Testing Methods
Genetic Sequencing
Clinical Diagnostics
Research & Development
Pharmaceutical Manufacturing
Environmental Testing
Food Safety Testing
Hospitals & Laboratories
Research Institutions
Pharmaceutical Companies
Biotechnology Firms
Food & Beverage Industries
Polymerase Chain Reaction (PCR)
ELISA (Enzyme-Linked Immunosorbent Assay)
Mass Spectrometry
Nucleic Acid Hybridization
Next-Generation Sequencing (NGS)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
For More Information or Query, Visit @ Viral Testing Market Research Analysis
1. Introduction of the Europe Viral Testing Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Market Size And Trends
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Viral Testing Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Viral Testing Market, By Type
6. Europe Viral Testing Market, By Application
7. Europe Viral Testing Market, By Geography
Europe
8. Europe Viral Testing Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Market Size And Trends
Market Size And Trends is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.marketsizeandtrends.com/